19 Jul 2017 | CannaTech News
With autoimmune disorders on the rise and standard treatments rendered ineffective, it might be time to look for an alternative solution, such as CBD
19 Jul 2017 | Leafly
The fear of being labeled a "stoner" can make some patients leave painful symptoms untreated. Others may avoid the doctor entirely.
16 Aug 2017 | Cashinbis
The National Institutes of Health awarded a $3.8 million grant to Albert Einstein College of Medicine and Montefiore Health System last week.
7 Jul 2017 | Nature
The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).
8 Aug 2017 | MarketWatch
GW Pharma’s Epidiolex could be the U.S.’s first cannabis-derived drug.
6 Jul 2017 | National Institute of Standards and Technology
NIST researchers have measured a fundamental physical property of the primary psychoactive compound in marijuana.
1 Jul 2017 | CannaTech News
Studies are increasingly suggesting that CBD could be the next vital medicine for a whole host of human medical conditions
30 Jun 2017 | Science Alert
A new study has investigated what patients themselves prefer when it comes to managing pain – opioids, which are widely distributed for intense pain relief, or medical marijuana.
29 Jun 2017 | Civilized
A pioneering study out of Pennsylvania will explore the effect of cannabis on children with autism. Researchers from Lehigh University plan to partner with a potential grower in the Lehigh Valley to collect quantitative data on cannabis therapy for autism.
26 Jun 2017 | Cashinbis
With drug overdoses now the leading cause of death among Americans under the age of 50, public health officials are scampering to find solutions to address the current opioid epidemic.